Clinical value of high‐frequency ultrasound and serum miR ‐92a‐3p in diabetic peripheral neuropathy
Journal of Diabetes Investigation · 2025
DOI: 10.1111/jdi.70110 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Investigation, 2025. Verfasst von Chunmei Qiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Ultrasound, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China. Hauptthemen laut MEDLINE: Diabetic Neuropathies, MicroRNAs, Diabetes Mellitus, Type 2, Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Inner Mongolia Natural Science Foundation Youth Fund Project, Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences.
Abstract (Originalsprache)
Aims/Introduction Cross‐sectional area (CSA) by high‐frequency ultrasound (HF‐US) detects morphologic changes in neuropathy. microRNA (miR)‐92a‐3p is linked to diabetes and nerve damage. Our study evaluated the diagnostic use of CSAs along with miR‐92a‐3p in diabetic peripheral neuropathy (DPN) and its relationship to the condition. Materials and Methods A total of 172 patients were enrolled, comprising 89 with DPN and 83 T2DM cases without DPN. Real‐time quantitative polymerase chain reaction (RT‐qPCR) was utilized to quantify serum miR‐92a‐3p levels. HF‐US detected CSA in the median, ulnar, and tibial nerves. Logistic regression analyzed potential risk factors for DPN occurrence and severity. Receiver operating characteristic curves assessed the diagnostic significance of miR‐92a‐3p and CSAs for DPN. Pearson coefficients evaluated the correlation between the Toronto Clinical Scoring System (TCSS) score and miR‐92a‐3p or CSAs.
Results
DPN patients had significantly higher serum miR‐92a‐3p levels and CSAs of the median, tibial, and ulnar nerves than T2DM patients. Moreover, miR‐92a‐3p and CSAs were risk factors for DPN. When combined, they yielded an AUC of 0.891, with 80.90% sensitivity and 91.57% specificity, accurately identifying DPN patients. Furthermore, miR‐92a‐3p and CSAs correlated with TCSS score and were higher in moderate‐to‐severe patients with DPN than in mild patients with DPN. Finally, miR‐92a‐3p combined with CSAs predicted moderate‐to‐severe DPN with 91.67% sensitivity and 85.37% specificity.
Conclusions
Serum miR‐92a‐3p and CSAs of median, ulnar, and tibial nerves are elevated in DPN patients. Their combination has high diagnostic significance in identifying DPN in T2DM patients and assessing its severity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Ultrasound, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
- Anesthesia Operation Center, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
- Department of Endocrinology, The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China.
ORCID-Profile: Xiaolei Wang
Förderung
- Inner Mongolia Natural Science Foundation Youth Fund Project
- Science and Technology Program of the Joint Fund of Scientific Research for the Public Hospitals of Inner Mongolia Academy of Medical Sciences
Zitieren
APA
Qiao, C., Liu, Z., Wang, B., Wang, X., Zhao, Z., Wang, H., & Wang, X. (2025). Clinical value of high‐frequency ultrasound and serum miR ‐92a‐3p in diabetic peripheral neuropathy. Journal of Diabetes Investigation. https://doi.org/10.1111/jdi.70110
Vancouver
Qiao C, Liu Z, Wang B, Wang X, Zhao Z, Wang H, et al. Clinical value of high‐frequency ultrasound and serum miR ‐92a‐3p in diabetic peripheral neuropathy. Journal of Diabetes Investigation. 2025. doi:10.1111/jdi.70110
BibTeX
@article{Qiao2025,
author = {Qiao, Chunmei and Liu, Zhenjiao and Wang, Boran and Wang, Xin and Zhao, Zifu and Wang, Hui and Wang, Xiaolei},
title = {Clinical value of high‐frequency ultrasound and serum miR ‐92a‐3p in diabetic peripheral neuropathy},
journal = {Journal of Diabetes Investigation},
year = {2025},
doi = {10.1111/jdi.70110}
}
EUVIMED